Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $71311.0.

  • iSpecimen's Change in Accured Expenses rose 12402.44% to $71311.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$305495.0, marking a year-over-year decrease of 536796.13%. This contributed to the annual value of -$371821.0 for FY2024, which is 406863.06% down from last year.
  • Latest data reveals that iSpecimen reported Change in Accured Expenses of $71311.0 as of Q3 2025, which was up 12402.44% from -$172687.0 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Change in Accured Expenses ranged from a high of $645675.0 in Q4 2022 and a low of -$2.3 million during Q2 2021
  • In the last 5 years, iSpecimen's Change in Accured Expenses had a median value of $657.0 in 2021 and averaged -$105360.4.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first surged by 9817625.57% in 2022, then plummeted by 216465.15% in 2023.
  • iSpecimen's Change in Accured Expenses (Quarter) stood at $657.0 in 2021, then surged by 98176.26% to $645675.0 in 2022, then decreased by 20.6% to $512647.0 in 2023, then tumbled by 71.44% to $146413.0 in 2024, then plummeted by 51.29% to $71311.0 in 2025.
  • Its Change in Accured Expenses was $71311.0 in Q3 2025, compared to -$172687.0 in Q2 2025 and -$350532.0 in Q1 2025.